Clinical Trial Update: Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating daunorubicin hydrochloride, cytarabine, and nilotinib in newly diagnosed adult acute myeloid leukemia has been completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin hydrochloride (daunorubicin hydrochloride)
• Nilotinib (nilotinib)

Snippet

Sponsor: Mayo Clinic | Conditions: Untreated Adult Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-11-14